Equalizing the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program

Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended— (1) by striking year, at least 7 and inserting “year— (I) for initial price applicability years 2026 and 2027, at least 7; and (2) by adding at the end the following: (II) for initial price applicability year 2028 and each subsequent initial price applicability year, at least 11 years will have elapsed since the date of such approval; and.